Mutation of the tumor suppressor Pten often leads to tumorigenesis in various organs including the uterus. We previously showed that Pten deletion in the mouse uterus using a Pgr-Cre driver (Pten 
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Introduction
Endometrial carcinoma (EMC) is the most common cancer of the female reproductive organs in the United States. In 2017, about 60,000 new cases were diagnosed and about 11,000 deaths occurred related to EMC in the US [1, 2] . EMC has been categorized into two major types: type I endometrioid cancers are focused in the endometrial gland cells, and type II non-endometrioid cancers are often of serous morphology. Type I represents approximately 85% of EMCs in which Pten is commonly mutated. Other than endometrial cancer, Pten mutations are also evident in endometrial hyperplasia [3] [4] [5] ; hyperplasia is a well-established precursor lesion of EMC [6] . The understanding of divergence between hyperplasia and cancer is of clinical significance. On one hand, faulty diagnosis of complex atypical hyperplasia (CAH) may lead to hysterectomy [7] , a non-reversible procedure that negatively impacts women seeking to preserve fertility. Alternatively, diagnosis at early stage of hyperplasia may prevent progression to carcinoma. Although stromal invasion and histological changes are considered diagnostic standards of EMC [8] , identification of the biomarkers for early stage carcinomas and the mechanism underlying cancer progression are greatly needed.
Pten homozygous null mice are embryonic lethal. Therefore, Pten heterozygous mice are widely used for cancer studies [6] . Pten heterozygous females show atypical endometrial hyperplasia phenotype, with 20% developing cancer. Using the Cre-loxP system and Pgr-Cre driver, we previously showed that Pten f/f
Pgr
Cre/+ mice with endometrial Pten deletion develop epithelial carcinoma as early as one month of age with Pten loss in major uterine cells [9] . To study roles of Pten in different uterine cell types, we created mice with Pten deletion specifically in the stroma and myometrium using Amhr2-Cre driver [10] . Pten f/f
/Amhr2
Cre/+ females showed no EMC; instead myometrial cells transformed into adipocytes [11] . Taken together, these findings suggest epithelial origin of this pathology. We thought that the epithelial origin of EMC could be tested if only epithelial-specific loss of Pten is induced in the uterus, disrupting the cross-talk between the stroma and epithelium to initiate EMC and its progression. To address this issue, an efficient Cre mouse line is necessary to specifically delete epithelial genes. Pten was conditionally deleted in the epithelium using Wnt7a-Cre, but the mutant pups died around 10 days of age [11] . Conditional deletion of Pten using Sprr2f-Cre met with failure because of brain cancer and limited life span [11, 12] . To generate a mouse line with Cre activity specifically in the adult uterine epithelium, we generated a mouse line expressing codonimproved Cre (iCre) under a Lactoferrin (Ltf) promoter. By crossing with LacZ reporter mice, we showed that the Ltf-driven iCre expression exhibits robust Cre activity in uterine luminal and glandular epithelia beginning at puberty [13] . In contrast to Cre expression driven by promoters of Pgr, Amhr2, and Wnt7a that occur before or right after birth, Cre activity driven by Ltf promoter is activated with the beginning of estrous cycle [13] .
In this study, using Ltf
Cre/+ mice, we established the mouse model with uterine epithelial- (Fig 2A and 2B) . We have previously shown that COX-2 expression is associated with endometrial cancer progression, and inhibition of COX-2 slows Cytokeratin can also be used to distinguish simple or stratified epithelium [28] . CK8 is produced by simple epithelia [29] , while CK5 is particularly expressed in the basal layer of stratified squamous epithelium. We found that the expression pattern of CK5 is similar to that of p63 ( Fig 3B) . Interestingly, co-staining of p63 or CK5 with CK8 identified that the expression pattern of p63/CK5 and CK8 are mutually exclusive in Pten f/f
Results

Conditional deletion of Pten in uterine epithelia leads to CAH without generation of EMC
Pgr
Cre/+ uteri ( Fig 3A and 3B ).
These results suggest a potential relationship between p63 and EMC. month of age are negative for p63 signal, but p63-positive cells appear underneath the CK8 positive luminal epithelium at 2 months of age ( Fig 3D) . These results provide evidence that stromal PTEN restrains epithelial stratification, and p63 serves as an indicator of EMC.
Stromal PTEN prevents transformation of CAH to EMC by promoting apoptosis
We explored the underlying mechanism preventing epithelial carcinoma by stromal PTEN. Remarkably, Ki67 staining is more intense in the CK8-negative luminal epithelium. These results were corroborated by co-staining of CK8, p63, and Ki67 staining on the consecutive sections ( Fig 4C) . Ki67 signals are localized in p63-positive epithelia. The staining of phosphor-Histone H3 (pHH3) in Pten f/f Pgr Cre/+ uteri also showed similar expression pattern to that of Ki67 (Fig 4B and 4C) . The results show that CK8 positive epithelial cells are proliferative in Uterine cell proliferation and differentiation is regulated by ovarian hormones through ESR1 [30] and PR [31] . We examined the expression of these two nuclear receptors. The results show that the expression of ESR1 and PR is maintained in all major cell types in both (Fig 5D) . However, no significant differences in CD206-positive M2 macrophages are observed (Fig 5E) . The quantification of M1 versus M2 macrophages is shown in Fig 5F and target genes, SERPINE1 and ID1, as compared to those in control tissues (Fig 6C) . This is consistent with low TGFβ levels in Pten f/f Pgr Cre/+ uteri. (Fig 6C) .
Increased epithelial apoptosis is associated with elevated macrophage infiltration
Discussion
PTEN is considered as a tumor suppressor protein. Pten mutations are closely related to various types of tumorigenesis, especially type I EMC [35] . Our present and previous studies using cell specific deletion of Pten in the uterus provide evidence that absence of Pten in the epithelium, stroma and myometrium promptly produces EMC, while its deletion in the stroma and myometrium fail to generate EMC but transforms myometrial cells to adipocytes. Surprisingly, Pten deletion specifically in the epithelium primarily shows CAH. The function of epithelial Pten has been studied using several approaches. Adenovirus was used to delete endometrial epithelial Pten by intraluminal injection [36] , although a small percentage of endometrial stromal cells of adeno-Cre injected mice showed Pten deletion. Conditional Pten deletion using Wnt7a-Cre and Ksp-Cre in combination with Pik3ca mutation was also reported [37] . Combination of Pten deletion and Pik3ca mutation leads to carcinoma, while Pik3ca mutation alone showed no EMC or hyperplasia phenotype. Similar to the CAH phenotype in the uterus, Pten deletion leading to hyperplasia has been corroborated in several other different epithelial tissues besides the endometrial epithelium, such as urothelial cells, keratinocytes, prostatic epithelial cells, and lung epithelium [6] . Furthermore, the glandular epithelium specific Pten deletion also showed endometrial hyperplasia [38] . As Pten is deleted in both luminal and glandular epithelia in our Ltf-iCre model, definitive answers to distinguish the role of Pten in the luminal or glandular epithelium will require a luminal epithelium-specific deletion mouse model. It is also of interest to evaluate the uterine phenotype in stroma and glandular-deletion or stroma and luminal-deletion of Pten using a combination of Cre systems.
Our study with Pten f/f Ltf Cre/+ uteri suggests that stromal Pten restrains transition of hyperplasia to carcinoma. In contrast, the deficiency of this gene in three major uterine cell types (Pten f/f Pgr Cre/+ ) with rapid generation of EMC suggests that Pten-deleted stroma provides a more susceptible microenvironment for further deterioration of hyperplastic epithelium into EMC. In this regard, the role of endometrial stroma in EMC was reported using a stromal-specific Lkb1-deleted mouse model in which the loss of Lkb1 in the stroma was sufficient to initiate neoplasia [39] . A previous study also showed that EMC develops in uteri with epithelial modification in both Pten and Pik3ca [37] . In the mouse uterus, epithelial deletion of Pten alone is not sufficient to induce EMC. In human cancer specimens, PTEN is predominantly lost in the epithelium and maintained in the stroma [40] . EMC was also observed in a transplant model, in which a mixture of Pten deficient epithelial cells and WT stromal cells were transplanted under kidney capsule [40] . In spite of these findings, many questions still remain about the differences between human and mouse models of cancers. Pgr Cre/+ mice at 3 months of age suggest that activation of mTORC1 is closely associated with hyperplasia. Our previous study using mice with whole uterine deletion of Tsc1 also supports this conclusion [41] . Interestingly, mice with Tsc1 deletion in the stroma and myometrium also shows hyperplasia, suggesting the existence of unidentified paracrine signals from stromal influencing epithelial proliferation. Furthermore, our results with rapamycin (an inhibitor of mTORC1 signaling) suggest that inhibition of mTORC1 signaling could be an effective preventive strategy to combat endometrial hyperplasia and/or EMC. We have also shown that inhibition of upregulated COX-2 in the uterus of Pten f/f Pgr Cre/+ mice is reduced by a COX-2 inhibitor (Celecoxib) with attenuated EMC development [22] . In the present study, COX-2 is also induced in hyperplasic Pten The current study demonstrates that the expression of p63 is closely associated with EMC development. However, the role of p63 in uterine luminal epithelial stratification is still not clear. p63 plays multiple roles in development depending on different contexts [42] . p63 is required for establishing stratified epithelia perhaps by maintaining stem cell populations or triggering differentiation of simple epithelia into stratified epithelia [43, 44] . In humans, p63 is expressed in hyperplastic and metaplastic endometria [25] . It is possible that p63 suppresses epithelial metaplasia and prevents epithelia from further invading into the muscle layer, since the loss of p63 in tumor tissues is associated with more aggressive EMC [26] . p63-positive cells invade the area underneath p63-negative columnar cells and push them upward, which leads to the detachment of p63-negative cells [45] . However, we cannot rule out the possibility that p63 itself promotes EMC development.
TGFβ signaling appears to constrain hyperplastic Pten f/f Ltf Cre/+ epithelia from stratification toward tumorigenesis. TGFβ acts as a tumor suppressor in the epithelium [46] and restricts epithelial growth and early tumor development [47] . In mouse uteri, TGFβr1 mRNA is detected mainly in the epithelia of Pten f/f Pgr Cre/+ uteri. SMAD2 is highly expressed in uterine epithelium at the proestrus phase. These results suggest a role for TGFβ in epithelial proliferation [48] . Pten and TGFβr1 double knockout mice using Pgr-Cre driver show severe endometrial lesions with disrupted myometrial layers and pulmonary metastasis [49] , suggesting a role for TGFβr1 in cancer progression. Mice with uterine stromal TGFβr1-deletion using Amhr2-Cre show enhanced proliferation in both luminal and glandular epithelia [50] , suggesting TGFβ signaling is involved in epithelial-stromal interactions. In this study, we observed PTEN levels are upregulated in the stroma of Pten f/f Ltf Cre/+ mice ( Fig 1A) and is associated with heightened stromal TGFβ and pSMAD2/3 levels. In contrast, TGFβ levels are suppressed in Pten f/f Pgr Cre/+ stroma, indicating stromal TGFβ signaling may play a role in preventing epithelial tumorigenesis. Taken together, these data indicate that Pten expression in the stroma maintains stromal TGFβ expression, which perhaps limits epithelial growth. TGFβ signaling plays a role in cell proliferation and apoptosis. In mouse uteri, reduced TGFβ signaling leads to loss of growth-inhibitory response, and constitutively activated TGFβr1 reduces glandular growth [51] , suggesting an inhibitory role for TGFβ in epithelial proliferation. TGFβ signaling also plays a role in cell apoptosis. In polarized endometrial epithelial cells, TGFβ induces apoptosis via SMAD3 [52] . Pten knockdown blocks TGFβ-induced apoptosis and leads to increased cell proliferation. We observed intense cell apoptosis in Pten Pten deletion in both the stroma and epithelium. Our data also imply that stromal regulation of epithelial growth is mediated by TGFβ signaling. Our current study presents new insights into the role of Pten in the microenvironment for tumorigenesis. 
Materials and methods
Mice
Immunohistochemistry and immunofluorescence
For paraffin sections, tissues were fixed in Safefix (Thermo Fisher Scientific, Lafayette, CO, USA) and embedded in paraffin. After deparaffinization and hydration, sections (6 μm) were subjected to antigen retrieval by autoclaving in 0.01M sodium citrate solution (pH = 6) for 10 min. For frozen tissues, sections (12 μm) were fixed in 4% paraformaldehyde solution.
Depending on the primary antibody (S1 Table) , some sections were subjected to antigen retrieval by autoclaving in 0.01M sodium citrate solution (pH = 6) for 10 min. COX-2 and TGFβ antibodies were custom-made as previously described [54, 55] . For immunohistochemistry, Histostain-Plus kit (Invitrogen, Carlsbad, CA, USA) was used to visualize signals. Immunofluorescence was performed using secondary antibodies conjugated with Alexa 488 or Alexa 594 (Jackson ImmunoResearch, West Grove, PA, USA). Hematoxylin and Hoechst were used for counterstain in immunohistochemistry and immunofluorescence, respectively. For all images of pHH3 staining at lower magnification, the maximum filter of ImageJ was applied to the red staining channel for clear visibility.
Quantification of macrophages
Numbers of M1 and M2 macrophages were calculated by counting MHCII and CD206 positive cells according to immunofluorescence staining. Sections from 3 different mice, and 4 fields per section have been evaluated.
In situ hybridization
cRNA probes for Pten were generated by reverse RT-PCR followed by 35 S-labeling using Sp6 or T7 RNA polymerases. Paraformaldehyde-fixed frozen sections (12 μm) were hybridized with 35 S-labeled cRNA probes of Pten as previously described [9] .
Western blotting
Western blotting was performed as previously described [11] . Briefly, uterine protein samples from uteri at the diestrous stage were run on 10 or 12% SDS-PAGE gels depending on the molecular weights of proteins and transferred onto PVDF membranes. After blocking in 5% BSA for detection of phosphorylated protein, or in 10% non-fat milk for detection other proteins, membranes were blotted with antibodies to PTEN, p-AKT, AKT, pS6, S6, p63 and β-ACTIN. Signals were detected using ECL reagents (GE healthcare, Pittsburgh, PA, USA).
TCGA analysis
RNAseq data were downloaded from TCGA data portal (https://tcga-data.nci.nih.gov/). RNAseq data from 176 UCEC cases and 23 controls were used for data analysis. Transcript-levels of genes were calculated using RNA-Seq by Expectation Maximization (RSEM) method.
Statistical analysis
Data were analyzed by the Mann Whitney tests. P<0.05 was considered significant. Values are mean ± SEM. 
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